Imagine a wheel with the patient at the hub: Surrounding and connecting the patient is the drug itself, wellness information, the physician, and the patient community. Promoting a brand effectively and responsibly means weaving a product into the community so that it plays a role in the patient's life beyond the drug. This sense of responsibility to the ultimate well-being of patients creates long-lasting trust.
Imagine a wheel with the patient at the hub: Surrounding and connecting the patient is the drug itself, wellness information, the physician, and the patient community. Promoting a brand effectively and responsibly means weaving a product into the community so that it plays a role in the patient's life beyond the drug. This sense of responsibility to the ultimate well-being of patients creates long-lasting trust.
The trend these days is toward smaller, more nimble shops. They can service clients with the same creative ideas, with less big agency overhead. Business as usual is harder to do with shrinking margins. Sometimes less is more, so spending time up front trying to determine what the client really needs, as opposed to what they think they need, can make the budget difference.
What clients really want is assurance their investments in the next phase of Web marketing will be effective. That's why we often suggest pilot programs with modest budgets for marketing executives to show proof of concept. The great thing about online initiatives is that they have the ability to produce quality ROI in real time. This gives us the ability to tweak programs on the fly. Almost always, these pilots prove to be successful and budgets grow.
Agencies need to be aware that FDA letters are bad for business. But they also have to find a way to keep the creative boundaries fresh. Agencies should always try to push the envel-ope toward more creative ways to tell a story or show a message. It's all about the balance.
Recent reports show that 250-plus biotechnology drugs or vaccines have been approved for almost 400 indications. 800 million people around the world have been treated with biologic technologies, and there are more than 300 biotech products in clinical trials. This emerging category stands to spark a new fire of strategic and creative thinking.
HC&B, located in Austin, TX, is an independent, full-service (including digital) healthcare agency.
Telephone: 512-320-8511
E-mail: kerry.hilton@hcbhealth.com
Web site: hcbhealth.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.